Stay updated on Isatuximab Combo in High-Risk Myeloma Clinical Trial

Sign up to get notified when there's something new on the Isatuximab Combo in High-Risk Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Isatuximab Combo in High-Risk Myeloma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The site footer revision updates from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-02T13:17:31.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A new study-record version dated October 19, 2026, was added and posted October 20, with a change to the study status. The page also displays an NIH notice about its terminology transition.
    Difference
    1%
    Check dated 2026-10-26T14:32:41.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T14:12:19.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-12T14:45:38.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.7.0 was added in the study record history, and the link text 'Find Contact Information' was changed to 'Find contact information' to adjust capitalization.
    Difference
    0.2%
    Check dated 2026-09-21T20:38:09.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The study record history shows a new revision entry v3.6.6 added. The previous v3.6.5 entry was removed.
    Difference
    0.1%
    Check dated 2026-08-31T17:30:28.000Z thumbnail image

Stay in the know with updates to Isatuximab Combo in High-Risk Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Isatuximab Combo in High-Risk Myeloma Clinical Trial page.